Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects
about
The Migraine-Stroke ConnectionPatent foramen ovale and migraine: no reason to interveneSustained long-term benefit of patent foramen ovale closure on migraine."Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolismMetabolic syndrome and migraine.The migraine association with cardiac anomalies, cardiovascular disease, and stroke.Patent Foramen Ovale and Migraine: Closing the Debate--A Review.Patent foramen ovale in patients with tension headache: is it as common as in migraineurs? An age- and sex-matched comparative studyThe role of cardiac and pulmonary pathology in migraine: a hypothesis.Migraine symptoms related to the percutaneous closure of an ostium secundum atrial septal defect: report of four paediatric cases and review of the literature.Transcatheter closure of intracardiac defects in adults.Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS).Migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation.Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.Headache and cardiovascular disease: old symptoms, new proposals.Migraine and patent foramen ovale.A retrospective review of clopidogrel as primary therapy for migraineurs with right to left shunt lesions.Practical implications of the migraine cardio- and cerebrovascular association: unmet needs of patients.The visual system in migraine: from the bench side to the office.Migraine with aura and patent foramen ovale: myth or reality?To Be or Not to Be Patent: The Relationship Between Migraine and Patent Foramen Ovale.New-onset and persistent migraine early after percutaneous atrial septal defect closure disappear at follow-up.Calcitonin gene-related peptide and size of the atrial septal defect in new-onset migraine after transcatheter closure: results of a preliminary study.Migraine: possible role of shear-induced platelet aggregation with serotonin release.Influence of transcatheter closure of atrial communication on migraine headache in patients with ischemic stroke.Migraine with aura and persistent foramen ovale.Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.Clopidogrel as prophylactic treatment for migraine: A pilot randomised, controlled studyPatent foramen ovale and atrial fibrillation as causes of cryptogenic stroke: is treatment with surgery superior to device closure and anticoagulation? A review of the literature
P2860
Q26747260-8279AF27-D840-463F-8BC7-E811014C12D0Q28217669-8B0845F0-3028-4CEF-97FD-CCA3FD2209A7Q33829743-87747289-8B65-44D5-BBE0-0940FF538F0AQ34613373-D0CDFB08-79A6-4E46-B7EF-C051E2B528BBQ34645695-1C4F0FBD-6F19-4E2C-A982-72FAD895508AQ34963196-8A4D46DB-BAD5-4A7C-A34C-1D2F2E1FCC0FQ35948573-6D2F3737-9639-4BC2-B93F-E34AF87BF190Q36332641-A1163AF7-9931-4DCD-9D77-6EE8A8DA9983Q36450688-DF5E7110-7F9B-4D14-8B6C-F04EDAC43CD2Q36801671-5255B8CC-809E-4AF9-B8AA-0C34498E8A33Q37016157-42EF9FBB-A5A5-4781-B78C-3B9B25E003B8Q37332388-632B7128-74A3-4EC9-99A3-FF8D8DE5D73CQ37701860-F63F09CE-6FD3-4034-B947-5154CB0091D6Q37710416-8BF1B2A7-6C84-4B25-A7A1-21FEEABC1C1BQ37798812-8D202B85-BFC9-4AAA-BF96-5673218356E8Q38176774-ED9F101D-25C3-47D7-A5CA-562EDDBEAC07Q38207479-8CF0750B-537C-41E1-A127-6DB1ECCECBBDQ38260996-12C7BDB3-B864-4598-A3DF-006DDF493395Q38347056-D178E180-6913-4CE3-BABE-C7FE769055EBQ38504718-2D469032-EB84-4BF8-AF69-5D727CD166B6Q40780568-30C13504-AB53-4C2E-BFAC-9983DEE56823Q47203550-266AA743-9D28-4180-BAD6-80F7ED4F216DQ47316999-98F53FA5-798C-4DEE-A5EE-0449D4594F5DQ47793574-B95AD259-73E9-4F9B-A51A-1195D5FEDC77Q49089413-96842900-190B-48BE-A2F0-DA706F0FE9FFQ50006074-91FDBC31-B516-4E57-BC95-B1EE6E013462Q53395358-45445810-E1B9-4AD5-8C1A-891C5C195F3DQ57624027-D2FDB92F-ABDD-4143-86B0-333129B2261DQ58713349-2F5AC78E-FD48-40D6-8DAC-2799EA226472
P2860
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@ast
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@en
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@nl
type
label
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@ast
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@en
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@nl
prefLabel
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@ast
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@en
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@nl
P2093
P2860
P3181
P356
P1433
P1476
Clopidogrel reduces migraine w ...... vale and atrial septal defects
@en
P2093
P T Wilmshurst
S Nightingale
W L Morrison
P2860
P304
P3181
P356
10.1136/HRT.2004.047746
P407
P577
2005-09-01T00:00:00Z